Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Efficacy, safety and pharmacokinetics of a novel subcutaneous immunoglobulin, Evogam®, in primary immunodeficiency(legacy) | 100 |
| Efficacy, safety and pharmacokinetics of a novel subcutaneous immunoglobulin, Evogam®, in primary immunodeficiency(legacy) | 81 |
Total Visits per Month
| December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
|---|---|---|---|---|---|---|---|
| Efficacy, safety and pharmacokinetics of a novel subcutaneous immunoglobulin, Evogam®, in primary immunodeficiency | 1 | 4 | 1 | 1 | 2 | 10 | 5 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 72 |
| China | 23 |
| Australia | 12 |
| Netherlands | 8 |
| France | 7 |
| Germany | 6 |
| Singapore | 5 |
| Vietnam | 5 |
| Argentina | 3 |
| Ireland | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 28 |
| Fairfield | 10 |
| Rotterdam | 8 |
| Beijing | 6 |
| Hanoi | 5 |
| Kaleen | 4 |
| Sydney | 4 |
| Cambridge | 3 |
| Seattle | 3 |
| Singapore | 3 |